Liabilities of Ascendis Pharma A/S from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Ascendis Pharma A/S quarterly Liabilities in EUR history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Ascendis Pharma A/S Liabilities for the quarter ending 31 Dec 2024 was €1,285,201,000, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (EUR)
Liabilities, YoY Quarterly Change (%)

Ascendis Pharma A/S Quarterly Liabilities (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 €1,285,201,000 +€313,917,000 +32% 31 Dec 2024 20-F 12 Feb 2025 2024 FY
Q3 2024 €1,191,103,000 +€244,457,000 +26% 30 Sep 2024 6-K 14 Nov 2024 2024 Q3
Q1 2024 €1,040,683,000 +€241,610,000 +30% 31 Mar 2024 6-K 02 May 2024 2024 Q1
Q4 2023 €971,284,000 +€144,894,000 +18% 31 Dec 2023 20-F 12 Feb 2025 2024 FY
Q3 2023 €946,646,000 +€124,778,000 +15% 30 Sep 2023 6-K 07 Nov 2023 2023 Q3
Q2 2023 €758,982,000 +€39,993,000 +5.6% 30 Jun 2023 6-K 05 Sep 2023 2023 Q2
Q1 2023 €799,073,000 +€94,639,000 +13% 31 Mar 2023 6-K 27 Apr 2023 2023 Q1
Q4 2022 €826,390,000 +€625,104,000 +311% 31 Dec 2022 20-F 07 Feb 2024 2023 FY
Q3 2022 €821,868,000 +€610,197,000 +288% 30 Sep 2022 6-K 02 Nov 2022 2022 Q3
Q2 2022 €718,989,000 +€554,628,000 +337% 30 Jun 2022 6-K 10 Aug 2022 2022 Q2
Q1 2022 €704,434,000 +€541,940,000 +334% 31 Mar 2022 6-K 11 May 2022 2022 Q1
Q4 2021 €201,286,000 +€60,204,000 +43% 31 Dec 2021 20-F 16 Feb 2023 2022 FY
Q3 2021 €211,671,000 +€117,132,000 +124% 30 Sep 2021 6-K 10 Nov 2021 2021 Q3
Q2 2021 €164,361,000 +€80,898,000 +97% 30 Jun 2021 6-K 27 Aug 2021 2021 Q2
Q1 2021 €162,494,000 +€89,919,000 +124% 31 Mar 2021 6-K 27 May 2021 2021 Q1
Q4 2020 €141,082,000 +€61,464,000 +77% 31 Dec 2020 20-F 02 Mar 2022 2021 FY
Q3 2020 €94,539,000 +€20,505,000 +28% 30 Sep 2020 6-K 12 Nov 2020 0
Q2 2020 €83,463,000 -€8,619,000 -9.4% 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q1 2020 €72,575,000 +€27,297,000 +60% 31 Mar 2020 6-K 19 May 2020 2020 Q1
Q4 2019 €79,618,000 +€40,700,000 +105% 31 Dec 2019 20-F 10 Mar 2021 2020 FY
Q3 2019 €74,034,000 +€43,005,000 +139% 30 Sep 2019 6-K 18 Nov 2019 2019 Q3
Q2 2019 €92,082,000 +€55,443,000 +151% 30 Jun 2019 6-K 28 Aug 2019 2019 Q2
Q1 2019 €45,278,000 +€27,865,000 +160% 31 Mar 2019 6-K 30 May 2019 2019 Q1
Q4 2018 €38,918,000 +€15,150,000 +64% 31 Dec 2018 20-F 03 Apr 2020 2019 FY
Q3 2018 €31,029,000 30 Sep 2018 6-K 28 Nov 2018 2018 Q3
Q2 2018 €36,639,000 30 Jun 2018 6-K 29 Aug 2018 2018 Q2
Q1 2018 €17,413,000 31 Mar 2018 6-K 30 May 2018 2018 Q1
Q4 2017 €23,768,000 +€10,310,000 +77% 31 Dec 2017 20-F 03 Apr 2019 2018 FY
Q4 2016 €13,458,000 31 Dec 2016 20-F 28 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.